$21 Million Awarded to Woman Disfigured By Dangerous Drug

Woman received $21 million from manufacturer of SulindacA federal jury in New Hampshire recently awarded $21 million to a woman who had filed a lawsuit against Mutual Pharmaceutical Company, alleging that the company was liable for injuries she suffered after taking a drug that they manufactured.

Karen Bartlett began taking the drug Sulindac in 2005 to treat her shoulder pain, the Nashua Telegraph reports. Two weeks after she began taking the drug, she noticed rashes on her face and irritation in her eyes.

She was admitted to a hospital for these symptoms, where she was diagnosed with Stevens-Johnson Syndrome (SJS), a potentially fatal inflammatory skin disease that burns off the top layer of skin and severely irritates mucus membranes, according to the Mayo Clinic.

According to the news source, Bartlett allegedly spent 112 days in hospitals and burn units, and suffered permanent damage to her throat, stomach and lungs due to her usage of the drug.

"It literally burned her alive," the plaintiff’s lawyer claimed. She also allegedly underwent 12 eye surgeries and is currently legally blind.

The plaintiff’s lawyer argued that Sulindac caused these injuries to Bartlett, citing that it has the highest reported incidents of SJS of any non-steroidal anti-inflammatory drug on the market, and that it should never have been distributed to patients at all, the news provider reports.

The jury found that Sulindac was unreasonably dangerous and awarded Bartlett $21 million.